rwwine,
When I first mentioned it was my Lotto pick I really meant it, I never would have guessed this nor had I ever expected anything close to this.
The only reason I bought it was because I made a killing in Arqule when it was bought in early Dec 2020 and I figured I could use a tax loss if it didn't pan out.
My original Tranche was a mere $15k which has grown to $739K in 9 months.
I'm not one to pump stocks, basically because you or I or anyone else on these boards could move it, but I really think TRIL has a long way to go.
They are still in PH 1 dose escalation studies and at their report this week they are not at MTD yet and are reporting 50% RR on patients that had 3 to 9 previous therapies (They also reported a couple of CR's along the way). The one thing you have to note is that their drugs were never ever supposed to used as an mono. Combo trials will start as soon as they find the MTD.
As always good luck and do your homework.
News 
Market Data 
Discover 
